Literature DB >> 777038

Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection.

M B Ray, V J Desmet, J Fevery, J De Groote, A F Bradburne, J Desmyter.   

Abstract

Chronic hepatitis was diagnosed on liver biopsy of 76 patients; 52 (68%)had HBsAg. Of the 52 patients with HBsAg, 23% had HBsAg shown by immunofluorescence on the liver, while it could not be detected with radioimmunoassay on the serum; 77% had HBsAg detectable in liver and in serum, and none had HBsAg in serum only. HBsAg was detected more frequently in chronic aggressive hepatitis and active cirrhosis than in chronic persistent hepatitis and cirrhosis with little activity. No correlation was found in the different forms of chronic hepatitis between the HBsAg status on the one hand, and levels of transaminases, gammaglobulins, and auto-antibodies on the other. Acute hepatitis was diagnosed on liver biopsy of 24 patients; 50% had HBsAg. Liver tissue positivity was very low in the fully developed stage compared to serum positivity. In 146 patients with other liver ailments, both liver and serum were negative for HBsAg.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 777038      PMCID: PMC475983          DOI: 10.1136/jcp.29.2.89

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

Authors:  W D Reed; R B Stern; A L Eddleston; R Williams; A J Zuckerman; A Bowes; P M Earl
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

4.  Morphological criteria in viral hepatitis. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

5.  Intranuclear aggregates in the liver of a patient with serum hepatitis.

Authors:  J M Nelson; L F Barker; S H Danovitch
Journal:  Lancet       Date:  1970-10-10       Impact factor: 79.321

6.  Hepatitis-associated antigen in chronic liver disease.

Authors:  M Velasco; R Katz
Journal:  Lancet       Date:  1970-04-11       Impact factor: 79.321

7.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

Review 8.  Immunopathology of viral hepatitis in man.

Authors:  W D Reed; A L Eddleston; R Williams
Journal:  Prog Med Virol       Date:  1974

9.  Intrahepatic expression of serum hepatitis virus-associated antigens.

Authors:  T S Edgington; D J Ritt
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

10.  The localization of Australia antigen by immunofluorescence.

Authors:  V E Coyne; I Millman; J Cerda; B J Gerstley; T London; A Sutnick; B S Blumberg
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

View more
  10 in total

1.  Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.

Authors:  J P Camilleri; C Amat; M Chousterman; J P Petite; A Duboust; A Boddaert; A Paraf
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-12-08

2.  HBsAg, chronic lymphoproliferative disorders, and cirrhosis of liver.

Authors:  R Heimann; M B Ray; V J Desmet
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

Review 3.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

4.  Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donors.

Authors:  J N Katchaki; T H Siem; R Brouwer
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

5.  Hepatic morphologic findings and viral antigens in acute hepatitis B. A longitudinal study.

Authors:  H J Houthoff; P Niermeijer; C H Gips; A Arends; N Hofstee
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

6.  Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients.

Authors:  M B Ray; V J Desmet; J Fevery; J De Groote; A F Bradburne; J Desmyter
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

7.  Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Authors:  W K Blenkinsopp; G P Haffenden
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

8.  Importance of showing HBsAg and HBcAg positivity in the liver for better aetiological definition of chronic liver disease.

Authors:  L Cuccurullo; M Rambaldi; G Iaquinto; F Ferraraccio; L Ambrosone; N Giardullo; A De Vita
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

9.  Long-term follow-up of chronic active hepatitis of moderate severity.

Authors:  J De Groote; J Fevery; L Lepoutre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

10.  HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis.

Authors:  T R Morgan; A G Redeker; S Yamada; M Ashcavai
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.